Paradigm Bio Cancels Shares in Buy-Back Scheme
Company Announcements

Paradigm Bio Cancels Shares in Buy-Back Scheme

Paradigm Biopharmaceuticals Ltd. (AU:PAR) has released an update.

Paradigm Biopharmaceuticals Ltd. has announced the cancellation of a total of 250,000 shares as part of an employee share scheme buy-back. The cessation of securities, which includes both ordinary fully paid shares and restricted shares, was effective as of April 5, 2024. This strategic move aligns with the company’s efforts to manage its share capital structure.

For further insights into AU:PAR stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskParadigm Biopharma Advances Phase 3 Trials Amid Financial Prudence
TipRanks Australian Auto-Generated NewsdeskParadigm Biopharmaceuticals Advances Phase 3 Trial Plans
TipRanks Australian Auto-Generated NewsdeskParadigm Biopharmaceuticals Plans New Securities Issuance
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App